We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+18.69%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$389B
AUM Growth
+$36.3B
Cap. Flow
-$17.4B
Cap. Flow %
-4.48%
Top 10 Hldgs %
19.75%
Holding
5,916
New
643
Increased
1,905
Reduced
2,520
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 14.23%
2 Consumer Discretionary 8.46%
3 Healthcare 7.67%
4 Financials 7.46%
5 Communication Services 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LPCN icon
5251
Lipocine
LPCN
$17.7M
$79K ﹤0.01%
+3,401
New +$81.9K
ABEO icon
5252
Abeona Therapeutics
ABEO
$397M
$77K ﹤0.01%
1,962
-7,413
-79% -$253K
CRBP icon
5253
Corbus Pharmaceuticals
CRBP
$179M
$76K ﹤0.01%
2,027
-1,668
-45% -$62.4K
RGLS
5254
DELISTED
Regulus Therapeutics
RGLS
$76K ﹤0.01%
+5,634
New +$41.4K
ARAV
5255
DELISTED
Aravive, Inc. Common Stock
ARAV
$75K ﹤0.01%
13,365
-7,635
-36% -$41.9K
FMAC.WS
5256
DELISTED
FirstMark Horizon Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one shar
FMAC.WS
$75K ﹤0.01%
+30,000
New +$58K
BKYI
5257
BIO-key International
BKYI
$4.55M
$74K ﹤0.01%
+117
New +$74.1K
GLDG
5258
GoldMining Inc
GLDG
$208M
$73K ﹤0.01%
+33,292
New +$76.3K
VCNX
5259
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$73K ﹤0.01%
+168
New +$70.3K
GRIN
5260
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
$73K ﹤0.01%
17,383
STEX
5261
Streamex Corp
STEX
$74.5M
$71K ﹤0.01%
1,825
-367
-17% -$16.1K
SUPV
5262
Grupo Supervielle
SUPV
$785M
$70K ﹤0.01%
32,944
+3,349
+11% +$6.34K
USIO icon
5263
Usio Inc
USIO
$65.7M
$70K ﹤0.01%
+26,182
New +$46.5K
GMBL
5264
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
0
LFWD icon
5265
ReWalk Robotics
LFWD
$20.5M
$68K ﹤0.01%
+616
New +$65.3K
BRMK.WS
5266
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$68K ﹤0.01%
250,000
PCTI
5267
DELISTED
PCTEL, Inc. Common Stock
PCTI
$66K ﹤0.01%
10,077
-1,818
-15% -$11K
CWBR
5268
DELISTED
CohBar, Inc. Common Stock
CWBR
$65K ﹤0.01%
+1,607
New +$54.3K
LXU icon
5269
LSB Industries
LXU
$697M
$64K ﹤0.01%
24,700
NHTC icon
5270
Natural Health Trends
NHTC
$14.7M
$64K ﹤0.01%
12,876
-3,292
-20% -$18.3K
NYMX
5271
DELISTED
Nymox Pharmaceutical Corp
NYMX
$63K ﹤0.01%
25,472
+1,858
+8% +$4.11K
AUTO
5272
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$63K ﹤0.01%
25,551
-730
-3% -$2.26K
CPSR.WS
5273
DELISTED
Capstar Special Purpose Acquisition Corp. Warrants, each whole warrant exercisable for one share of
CPSR.WS
$63K ﹤0.01%
+45,000
New +$44.6K
CRNT icon
5274
Ceragon Networks
CRNT
$203M
$62K ﹤0.01%
22,135
+7,143
+48% +$18.3K
VIRX
5275
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$62K ﹤0.01%
8,968
+5,502
+159% +$28.7K

Similar funds

Goldman Sachs's Q4 2020 Portfolio in Review

As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.

  • Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
  • Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
  • Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
  • Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
  • Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
  • Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
  • Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.